论文部分内容阅读
第三代靶向药已进入中国肺癌指南最早出现的肺癌靶向药物被称为第一代靶向药物,相比放化疗,能精准抑制肿瘤,副作用小,已经使患者生存期显著延长,生活质量提高。但是,一代、二代靶向药治疗后都会发生耐药的问题,因此我们又相继有了第三代靶向药。第三代靶向药作用于引起耐药的特定基因(T790M)突变,这个基因在一代、二代耐药患者中最
The third generation of targeted drugs has entered the Chinese lung cancer guidelines The earliest lung cancer targeted drugs known as the first generation of targeted drugs, compared with radiotherapy and chemotherapy, can accurately inhibit the tumor, the side effects of small, patients have been significantly prolonged survival, life Quality improvement. However, one generation and two generations of targeted drugs will have drug resistance problems, so we have followed the third generation of targeted drugs. The third generation of targeted drugs on the specific resistance-causing gene (T790M) mutation, this gene in the first and second generation of drug-resistant patients